SRPT 12/31/2020 10-K

Company

Sarepta Therapeutics, Inc.

Filed

March 1, 2021

Period of Report

December 31, 2020

Accession Number

0001564590-21-009835

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →